Integrated Annual Report 2023 2 3 4 5 6 7 8 9 1 321 NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 18. INVESTMENT IN SUBSIDIARIES Company 2023 RM’000 2022 RM’000 Unquoted shares, at cost (Note (a)): - Malaysian subsidiaries 1,872,019 1,871,259 - Foreign subsidiaries 217,302 217,302 2,089,321 2,088,561 Less: Accumulated impairment (Note (b)) (415,300) (415,300) 1,674,021 1,673,261 (a) Cost of investment in subsidiary companies Note Company 2023 RM’000 2022 RM’000 At 1 January 2,088,561 1,956,923 Incorporation of Edgenta Academy Sdn. Bhd. (i) 10 - Acquisition of additional share capital in subsidiaries (ii) 750 100 Capitalisation of amounts due from Edgenta (Singapore) Pte. Ltd. (“ESG”) (iii) - 130,925 Incorporation of Edgenta Arabia Limited (“EAL”) (iv) - 613 At 31 December 2,089,321 2,088,561 (i) Incorporation of Edgenta Academy Sdn. Bhd. (“EASB”) On 12 September 2023, EASB was incorporated as a wholly-owned subsidiary of the Company. (ii) Acquisition of additional share capital in subsidiaries On 19 April 2023, Edgenta Healthcare Management Sdn. Bhd., increased its ordinary shares to 750,000 by issuing new ordinary shares of RM1.00 each. The Company subscribed to the new shares which was settled by cash. In previous financial year, Edgenta FIRST Sdn. Bhd., increased its ordinary shares to 100,000 by issuing new ordinary shares of RM1.00 each. The Company subscribed to the new shares which was settled by cash.
RkJQdWJsaXNoZXIy NDgzMzc=